These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27105305)

  • 1. A no-brainer for ending AIDS: the case for a harm reduction decade.
    Cook C; Lines R; Wilson DP
    J Int AIDS Soc; 2016; 19(1):21129. PubMed ID: 27105305
    [No Abstract]   [Full Text] [Related]  

  • 2. Performance of the Antiretroviral Treatment Program in Ethiopia, 2005-2015: strengths and weaknesses toward ending AIDS.
    Assefa Y; Gilks CF; Lynen L; Williams O; Hill PS; Tolera T; Malvia A; Van Damme W
    Int J Infect Dis; 2017 Jul; 60():70-76. PubMed ID: 28533167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Southern Harm Reduction Coalition for HIV Prevention: Advocacy Accomplishments.
    Story CR; ; Kao WK; Currin J; Brown C; Charles V
    Health Promot Pract; 2018 Sep; 19(5):695-703. PubMed ID: 29186992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of the RADPAD Surgical Cap in Reducing Brain Exposure During Pacemaker and Defibrillator Implantation.
    Lemesre C; Graf D; Bisch L; Carroz P; Cherbuin N; Damet J; Desorgher L; Siklody CH; Le Bloa M; Pascale P; Pruvot E
    JACC Clin Electrophysiol; 2021 Feb; 7(2):161-170. PubMed ID: 33602396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ending the HIV/AIDS Pandemic
    Eisinger RW; Fauci AS
    Emerg Infect Dis; 2018 Mar; 24(3):413-416. PubMed ID: 29460740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis.
    Marzel A; Kusejko K; Weber R; Bruggmann P; Rauch A; Roth JA; Bernasconi E; Calmy A; Cavassini M; Hoffmann M; Böni J; Yerly S; Klimkait T; Perreau M; Günthard HF; Kouyos RD;
    Open Forum Infect Dis; 2018 May; 5(5):ofy078. PubMed ID: 29868622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The state of harm reduction in the Middle East and North Africa: A focus on Iran and Morocco.
    Himmich H; Madani N
    Int J Drug Policy; 2016 May; 31():184-9. PubMed ID: 27012581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs.
    Tookes HE; Oxner A; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; McCollister K; Rodriguez A; Kolber MA; Chueng TA; Zayas S; McCoy B; Sutherland K; Archer C; Bartholomew TS
    Trials; 2023 Feb; 24(1):96. PubMed ID: 36750867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ending the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?
    Harries AD; Suthar AB; Takarinda KC; Tweya H; Kyaw NT; Tayler-Smith K; Zachariah R
    F1000Res; 2016; 5():2328. PubMed ID: 27703672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
    Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
    Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting.
    Rudzinski K; Chan Carusone S; Ceranto A; Ibáñez-Carrasco F; McDonald L; Valentine D; Guta A; Hyshka E; O'Leary W; Cardow A; Strike C
    Harm Reduct J; 2022 Nov; 19(1):124. PubMed ID: 36384634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bangkok 2004. The spread of harm-reduction programs in Brazil.
    Teixeira LP
    HIV AIDS Policy Law Rev; 2004 Dec; 9(3):94-5. PubMed ID: 15812931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Backlash in global health and the end of AIDS' exceptionalism in Brazil, 2007-2019.
    Cueto M; Lopes G
    Glob Public Health; 2022 Jun; 17(6):815-826. PubMed ID: 33689577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earth science a 'no-brainer' for NASA's science chief.
    Voosen P
    Science; 2017 Mar; 355(6330):1112. PubMed ID: 28302804
    [No Abstract]   [Full Text] [Related]  

  • 16. [E-health--a no-brainer?].
    Rausch R
    Med Monatsschr Pharm; 2015 Jun; 38(6):201. PubMed ID: 26364369
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre-implantation genetic diagnosis (PGD): the spectre of eugenics or a "no brainer".
    Baum M
    Int J Surg; 2006; 4(3):144-5. PubMed ID: 17462336
    [No Abstract]   [Full Text] [Related]  

  • 18. Why Mindfulness/Meditation Is a "No-Brainer" for Health-Care Professionals.
    Calabrese LH
    J Patient Exp; 2019 Mar; 6(1):21-23. PubMed ID: 31236447
    [No Abstract]   [Full Text] [Related]  

  • 19. Taking inspiration from nature is a no-brainer.
    Matsiko A
    Sci Robot; 2023 May; 8(78):eadi2720. PubMed ID: 37256967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dentists greet 'no brainer' investment to boost access and future proof services.
    Br Dent J; 2021 Jun; 230(12):793. PubMed ID: 34172849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.